Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A2 | Q12908 | 20/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6767888 | 0.85 | SLC10A2 (1.00) | SLC10A2 | |
| SCHEMBL6767903 | 0.83 | SLC10A2 (0.87) | SLC10A2 | |
| SCHEMBL6716258 | 0.76 | SLC10A2 (0.83) | SLC10A2 | |
| SCHEMBL6716253 | 0.75 | SLC10A2 (0.73) | SLC10A2 | |
| SCHEMBL6922272 | 0.70 | SLC10A2 (1.00) | SLC10A2 | |
| SCHEMBL6716347 | 0.70 | SLC10A2 (1.00) | SLC10A2 | |
| SCHEMBL6716356 | 0.68 | SLC10A2 (0.86) | SLC10A2 | |
| SCHEMBL12067862 | 0.67 | SLC10A2 (0.90) | SLC10A2 | |
| SCHEMBL27307948 | 0.67 | SLC10A2 (0.60) | SLC10A2 | |
| SCHEMBL6713350 | 0.66 | SLC10A2 (1.00) | SLC10A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176438-A1 | Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake | G.D. SEARLE, LLC | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176438-A1 | Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake | SLC10A1, SLC10A2, ABCB11 | SLC10A2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.